Jerónimo Rafael Rodríguez‐Cid
- Co-authors
- Ali TafreshiLuis Paz‐AresYing ChengJulien MazièresBalázs HalmosDavid VicenteBilal PiperdiAndrew Robinson
- Topics
- Cancer Immunotherapy and Biomarkers (11 papers)Lung Cancer Treatments and Mutations (11 papers)Lung Cancer Diagnosis and Treatment (7 papers)
- Partner nations
- MexicoUnited StatesJapan
In The Last Decade
Jerónimo Rafael Rodríguez‐Cid
26 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 970
- Pulmonary and Respiratory Medicine 746
- Immunology 130
- Molecular Biology 86
- Epidemiology 83
Countries citing papers authored by Jerónimo Rafael Rodríguez‐Cid
This map shows the geographic impact of Jerónimo Rafael Rodríguez‐Cid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerónimo Rafael Rodríguez‐Cid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerónimo Rafael Rodríguez‐Cid more than expected).
Fields of papers citing papers by Jerónimo Rafael Rodríguez‐Cid
This network shows the impact of papers produced by Jerónimo Rafael Rodríguez‐Cid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerónimo Rafael Rodríguez‐Cid. The network helps show where Jerónimo Rafael Rodríguez‐Cid may publish in the future.
Co-authorship network of co-authors of Jerónimo Rafael Rodríguez‐Cid
This figure shows the co-authorship network connecting the top 25 collaborators of Jerónimo Rafael Rodríguez‐Cid. A scholar is included among the top collaborators of Jerónimo Rafael Rodríguez‐Cid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerónimo Rafael Rodríguez‐Cid. Jerónimo Rafael Rodríguez‐Cid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Studybreakdown → | 233 |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 15 | |
| 9 | 130 | |
| 10 | 2 | |
| 11 | 37 | |
| 12 | A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407breakdown → | 409 |
| 13 | 7 | |
| 14 | 1 | |
| 15 | Clinical-epidemiological and molecular description of lung cancer in a national reference center | 0 |
| 16 | 66 | |
| 17 | 57 | |
| 18 | 6 | |
| 19 | 2 | |
| 20 | Uso de ipilimumab en pacientes con melanoma metastásico. Experiencia en el Hospital Médica Sur | 1 |
About Jerónimo Rafael Rodríguez‐Cid
Jerónimo Rafael Rodríguez‐Cid is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Lung Cancer Diagnosis and Treatment (7 papers). The work is most often cited by research in Oncology (970 citations), Pulmonary and Respiratory Medicine (746 citations) and Immunology (130 citations). Jerónimo Rafael Rodríguez‐Cid has collaborated with scholars based in Mexico, United States and Japan. Frequent co-authors include Ali Tafreshi, Luis Paz‐Ares, Ying Cheng, Julien Mazières, Balázs Halmos, David Vicente, Bilal Piperdi, Andrew Robinson, Dariusz M. Kowalski and Bárbara Hermes. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.